These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 26928310

  • 1. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
    Yılmaz S, Özçakar ZB, Taktak A, Kiremitçi S, Ensari A, Dinçaslan H, Yalçınkaya F.
    Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of Sorafenib and Bevacizumab on pancreatic volume - A monocentric CT based analysis.
    Phillip V, Zahel T, Bärtl K, Rasch S, Ebert O, Schmid RM, Rummeny E, Algül H.
    Pancreatology; 2016 Jun; 16(4):621-4. PubMed ID: 26968257
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathologic Correlation with Renal Dysfunction after Intravitreal Injections of Vascular Endothelial Growth Factor Antagonists.
    Zhang PL, Raza S, Li W, Kanaan HD.
    Ann Clin Lab Sci; 2021 Nov; 51(6):875-882. PubMed ID: 34921042
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.
    Falchook GS, Wheler JJ, Naing A, Piha-Paul SA, Fu S, Tsimberidou AM, Hong DS, Janku F, Zinner R, Jiang Y, Huang M, Lin Q, Parkhurst K, Kurzrock R.
    Invest New Drugs; 2015 Feb; 33(1):215-24. PubMed ID: 25363205
    [Abstract] [Full Text] [Related]

  • 18. Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature.
    Hilburg R, Geara AS, Qiu MK, Palmer MB, Chiang EY, Burger RA, Hogan JJ.
    Clin Nephrol; 2021 Jul; 96(1):51-59. PubMed ID: 33896447
    [Abstract] [Full Text] [Related]

  • 19. Thrombotic microangiopathies and antineoplastic agents.
    Grangé S, Coppo P, Centre de référence des microangiopathies thrombotiques (CNR-MAT)Centre de référence des microangiopathies thrombotiques (CNR-MAT), AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France..
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S109-S113. PubMed ID: 28577731
    [Abstract] [Full Text] [Related]

  • 20. A severe case of bevacizumab-induced thrombotic microangiopathy.
    Bektas M, Samancı NS, Cokgezer S, Keskin D, Demirelli FH.
    J Oncol Pharm Pract; 2019 Oct; 25(7):1754-1757. PubMed ID: 30253727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.